semaglutide vs tirzepatide doses Comparison of and Statistical Weight Loss Tirzepatide vs. Semaglutide for Weight

Wegovy is FDA-approved for chronic weight management in individuals who are obese (patients with a BMI of 30 or greater) or overweight (BMI 27 or more) with at least one weight-related health condition

Bioavailability is lower than injectable semaglutide, which is why the oral doses are much higher

Compounded tirzepatide, the formulations prepared by compounding pharmacies , sometimes comes with different storage instructions

However, possible side effects include nausea, vomiting, constipation, and stomach pain

It's essential to recognize that complete elimination varies among individuals based on multiple physiological factors

For instance, over 104 weeks with semaglutide 2.4 mg, participants achieved a mean weight loss of around 15% of baseline weight